Palani vs. The Tamil Nadu State
Background
The appellant, a doctor running a clinic, had his premises inspected in 2015, and officials found 29 types of allopathic medicines being kept without a proper sale licence. He was tried and convicted by a magistrate under two provisions of the Drugs and Cosmetics Act (one relating to possession for sale/distribution without a licence, and another relating to failure to disclose the manufacturer's name) and sentenced to a total of about eight months' imprisonment plus fines. On appeal, the lower appellate court had already set aside the conviction for possession-for-sale (finding no evidence the drugs were actually being sold), but upheld the conviction for non-disclosure of the manufacturer. A revision against that was also dismissed, leading to this final appeal on the question of sentence.
Decision Breakdown
The Supreme Court did not disturb the conviction itself (which was for the narrower offence of not disclosing where the medicines came from) but modified the sentence. Relying on its own precedent that sentencing should account for factors like the offender's background and circumstances, and given that the appellant was a doctor with only a small quantity of medicines involved, the Court held that the non-disclosure, while an offence, did not endanger public safety enough to justify imprisonment, especially since the more serious charge of selling/distributing had already been found not proven. It replaced the six-month prison sentence with a fine of Rs. 1,00,000.
Lesson Learnt
Even after a conviction is upheld, the Supreme Court can still tailor the punishment to fit the real culpability involved: a technical regulatory lapse (like not naming a supplier) does not automatically deserve the same punishment as a more serious offence like illegal sale, and courts are expected to weigh the offender's circumstances, not just the bare provision violated.